220 likes | 447 Views
SIRT6 and the disease of aging. Mark Devries. Outline . Background Sirtuin biology SIRT6 role in aging Results Phylogeny Protein domains Phenotype DNA motifs Possible protein modifications Chemical activators Protein interactions Future directions.
E N D
SIRT6 and the disease of aging Mark Devries
Outline • Background • Sirtuin biology • SIRT6 role in aging • Results • Phylogeny • Protein domains • Phenotype • DNA motifs • Possible protein modifications • Chemical activators • Protein interactions • Future directions
FunctionHistone Deacetylases (HDAC) • Class I and II • Zinc dependant deacetylase • Class III • NAD+ dependant deacetylase • SIRT6 has deacetylase activity (Du et al., 2009)
SIRT6 Protein • 355 AA protein • localizes to nucleus • Interacts NF-kB (Kawahara et al., 2008) and deacetylates H3K9 (Michishita et al., 2008)
SIRT 6 phenotype • Phenotype • Shorter lifespan • Genomic instability Mostoslavsky et al 2006
What are the signs SIRT6 leads to aging phenotype? • Increase expression of aging genes • Decreased IGF-1 levels • Increased genomic instability • Other signs of aging related disease
Phylogeny T-Coffee
Protein domain • Sirtuin domain • Rossman fold • Cystine residues Picture retrieved from www.topsan.org
Chemical • No inhibitors or activators • Resveratrol an activator? • Room for discovery How much resveratrol does it take to activate Sirtuins? • 200uM concentration usually for activation • Which equal 1.824g of resveratrol • 12,160 glasses of wine
Summary • Numerous DNA motifs ( Myc, Rel, MZF1) • Many sites of phosphorlation/ Sumoylation • No known activators or inhibitors • Possible interaction with ELF5
Future directions • Co-immunoprecipitationfor interaction with ELF5 • MS to see if SIRT6 is modified • Western blots to determine if sumolated • Chemical library screens to determine new inhibitors and activators
References • Michishita, E., McCord, R.A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T.L., Barrett, J.C., et al. (2008). SIRT6 is a histone h3 lysine9 deacetylase that modulates telomeric chromatin. Nature 452, 492-496. doi:10.1038/nature06736 • Mostoslavsky, R., Chua, K.F., Lombard, D.B., Pang, W.W., Fischer, M.R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M.M., et al. (2006). Genomic instability and aging like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329. doi:10.1016/j.cell.2005.11.044 • Kawahara, T.L., Michishita, E., Adler, A.S., Damian, Mara., Berber, E., Lin, Meihong., McCord, R.A., Ongaigui, K.C., Boxer, L.D., Chang, H.Y., Chua, K.F. (2008). SIRT6 links histone H3 lysine 9 deacetylation to NF-kB-dependent gene expression and organismal life span. Cell 136, 62-74. doi: 10.1016/j.cell.2008.10.052 • Sauve A.A., Celic I., Avalos J., Deng H., Boeke J.D., Schramm V.L. (2001). Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions. Biochemistry 40:15456-15463 doi: 10.1021/bi011858j • Dutnail, R.N., Pillus, L. (2001). Deciphering NAD-Dependent Deacetylases. Cell 105, 161-164. doi:10.1016/S0092-8674(01)00305-1